Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococcal Vaccine Schedules Acquisition-Immunogenicity
PACTR202105670402672Phase 4Recruiting
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jul 2020
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Prevnar 13 and 17D yellow fever vaccine in pneumococcal disease (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Started Jul 2020; status: recruiting.
02
Drugs
Prevnar 1317D yellow fever vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on PACTR202105670402672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202105670402672.